The functional integrity of the small bowel is impaired in coeliac disease. Intestinal permeability, as measured by the sugar absorption test probably reflects this phenomenon. In the sugar absorption test a solution of lactulose and mannitol was given to the fasting patient and the lactulose/mannitol ratio measured in urine collected over a period of five hours.
sugar absorption test a solution of lactulose and mannitol was given to the fasting patient and the lactulose/mannitol ratio measured in urine collected over a period of five hours. The sugar absorption test was performed in nine patients with coeliac disease with an abnormal jejunum on histological examination, 10 relatives of patients with coeliac disease with aspecific symptoms but no villous atrophy, six patients with aspecific gastrointestinal symptoms but no villous atrophy, and 22 healthy controls to determine whether functional integrity is different in these groups. The lactulose/mannitol ratio (mean (SEM) is significantly higher in both coeliac disease (0.243 (0.034), p<0 0001)) and relatives of patients with coeliac disease (0.158 (0.040), p<0 005)) v' both healthy controls (0.043 (0.006)) and patients with aspecific gastrointestinal symptoms (0.040 (0.011)). The lactulose/mannitol ratio in relatives of coeliac disease patients was significantly lower than in the coeliac disease patient group (p=0.04).
The lactulose/mannitol ratio was the same in healthy controls and patients with aspecific gastrointestinal symptoms. It is concluded that the sugar absorption test is a sensitive test that distinguishes between patients with coeliac disease and healthy controls. The explanation for the increased permeability in relatives of patients with coeliac disease is uncertain. Increased intestinal permeability may be In other immunological gastrointestinal diseases such as food allergy, it has been suggested that disturbances in the functional integrity, responsible for the barrier function of the small bowel mucosa, could play a role in the development of clinical symptoms. In 'full blown' coeliac disease, the histology of the mucosal structure, as well as the functional integrity of the small bowel mucosa, are impaired."' If latent coeliac disease is a precurser of coeliac disease itself, the functional integrity of the small bowel could already be altered before gross histological abnormalities are found.
Intestinal permeability, as measured by the 
Methods
After an overnight fast the patient emptied his or her bladder and drank a solution containing 2 g mannitol, 5 g lactulose and 40 g sucrose, made up to 100 ml with demineralised water, to give an osmolality of approximately 1 650 mosm/l. For the first 2 hours after drinking the test fluid, no food or fluid was allowed and all the urine passed in the 5 hours after they had drunk the test fluid was collected. Chlorohexidine digluconate 20% (0 5 ml) was added to the urine as a preservative. The urine volume was measured and aliquots were stored frozen at 20°C. To calculate the lactulose/mannitol ratio samples were analysed for lactulose and mannitol by gas chromatography as previously described.
STATISTICAL ANALYSIS
The non-parametric Mann-Whitney U test was used for statistical analysis of the data. A p value <0 05 was considered statistically significant.
Results
The mean lactulose/mannitol ratio in urine from the four groups is summarised in Table II. The lactulose/mannitol ratio in coeliac disease patients is significantly higher than in both the healthy controls (p<0-0001) and in patients with aspecific gastrointestinal symptoms (p=0002).
The lactulose/mannitol ratio in relatives of coeliac disease patients is significantly lower than in coeliac disease patients (p=0-04) but significantly higher than that in either healthy controls (p<0-0001) and patients with aspecific gastrointestinal symptoms (p=0002). The lactulose/ mannitol ratio is not significantly different in healthy controls and patients with aspecific gastrointestinal symptoms (p= 0 74).
The mean levels of mannitol excretion in urine in the four groups are summarised in Table II. The differences between the groups are not significant. The mean levels of urinary lactulose excretion in the four groups are summarised in Table II. The differences between the groups are generally similar to the differences in the lactulose/mannitol ratio. The differences between coeliac disease patients and relatives of coeliac disease patients, however, can only be seen in the lactulose/mannitol ratio (p=0 04) and not in the urinary lactulose excretion alone (p=0* 17).
An lactulose/mannitol ratio 0 099 (mean (+2SD)) is considered abnormal. On this basis, in eight of nine coeliac disease patients, seven of 10 relatives of coeliac disease patients, none of six patients with aspecific gastrointestinal symptoms, and one of 22 healthy controls were found to have abnormal lactulose/mannitol ratio ( Figure) . In this study the sugar absorption test was performed to determine whether relatives of coeliac disease patients, who are known to be at risk of developing coeliac disease, have functional changes comparable with coeliac disease patients. We showed that the lactulose/ mannitol ratio in these relatives is significantly higher than in both healthy controls and patients with aspecific gastrointestinal symptoms. The relatives' lactulose/mannitol ratio is, however, still significantly lower than that in coeliac disease patients. The latter two groups cannot be differentiated by lactulose excretion alone. The increase in lactulose excretion in coeliac disease may reflect epithelial injury, cell shedding, or changes in the intercelluar tight junctions. 12 Mannitol, which is quite similar in size to xylose, could not differentiate between any group. This confirms the higher sensitivity of the lactulose/ mannitol ratio than the use of one marker, like lactulose. In a recent study, we compared the sugar absorption test with the xylose test in detecting impaired mucosal function and found that the sensitivity of the sugar absorption test is much better than that of the xylose test, whereas the specificity was equal. '3 Untreated coeliac disease patients have an increased risk of intestinal malignancies. 14 For that reason, it seems reasonable to screen first degree relatives whose risk of developing asymptomatic coeliac disease is as high as 10%. None of the 10 relatives showed signs of villous atrophy on histological examination of the small bowel but seven of 10 had increased intestinal permeability. Of these seven, two were asymptomatic while, three showed increased intraepithelial lymphocytes. Therefore, in our study no clear correlation seems to exist between increased intestinal permeability, histological abnormalities of the small bowel, or the occurrence of aspecific gastrointestinal symptoms.
Increased intestinal permeability could facilitate the interaction of gluten with the human immune system thus leading to the production of IgA antibodies and (after prolonged exposure to gluten) to histological damage of the mucosa. It seems unlikely, however, that increased intestinal permeability is a primary factor in the development of coeliac disease. In two recent studies, coeliac disease patients on a gluten free diet had normal intestinal permeability but did react to gluten challenge with an increase in intestinal permeability. '5 6 There are two possible explanations for the finding that intestinal permeability was increased in seven of 10 
